Stocks›Healthcare›CRL

CRL

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

NYSEResearch view

$292.84−0.54%

Sep 25 close · 1D EOD · Databento

HealthcareServices-Commercial Physical & Biological ResearchLarge-capSEC EDGAR FY 2025-12-27

What happened

Daily closes · dots are Wire stories

What’s next

Expected around early November, going by its own filing history. The company has not announced a date yet. Its matching report came Nov 5, 2025 and Nov 6, 2024, before the open.

Last report

Aug 5, 2026+11.36%

before the open

Last 4, next close

median 0.21% either way

up 2 of 4

Every report since 2023 →

DateEventSourceNext close

Aug 5Earnings release, before the open · 8-KSEC EDGARSEC EDGAR ↗+11.36%

Next close = the first close after the event against the close before it. Prior-session closes only; not a call, not advice.

Big days · last year

Daily closes · Databento EOD

22 big days: a close more than 4.80% from the one before, three times CRL’s median day (1.60%). On 13 of 22, its largest peers moved the same way at least half as far. We show what we hold, never a cause.

Shaded: since our stories began, May 26, 2026

22Sep 24, 2026
Sep 24, 2026Nothing in our recordNo CRL story, brief or results filing in our record that dayGroup +1.6% did not move with it
+1.6% did not move with itICLR +6.1 · IQV +2.7 · MEDP +0.6 · INCY −0.2
+6.17%
21Aug 5, 2026
Aug 5, 2026ResultsThe first close after a results filing (SEC 8-K, Item 2.02)Group +2.8% did not move with it
+2.8% did not move with itICLR +4.3 · IQV +3.4 · MEDP +2.2 · INCY −0.7
+11.36%
20Jul 28, 2026
Jul 28, 2026Nothing in our recordNo CRL story, brief or results filing in our record that dayGroup +8.0% moved the same way
+8.0% moved the same wayIQV +13.9 · INCY +9.3 · ICLR +6.8 · MEDP −3.1
+7.19%
19Jul 23, 2026
Jul 23, 2026Nothing in our recordNo CRL story, brief or results filing in our record that dayGroup +3.1% moved the same way
+3.1% moved the same wayMEDP +14.7 · IQV +4.4 · ICLR +1.8 · INCY +0.8
+4.84%
18Jun 25, 2026
Jun 25, 2026Nothing in our recordNo CRL story, brief or results filing in our record that dayGroup +0.9% did not move with it
+0.9% did not move with itICLR +1.8 · MEDP +1.4 · INCY −0.9 · IQV +0.4
+5.25%
17Jun 24, 2026
Jun 24, 2026Nothing in our recordNo CRL story, brief or results filing in our record that dayGroup +8.3% moved the same way
+8.3% moved the same wayICLR +10.9 · IQV +8.4 · MEDP +8.3 · INCY +3.9
+8.31%
16May 28, 2026
May 28, 2026Nothing in our recordNo CRL story, brief or results filing in our record that dayGroup +7.0% moved the same way
+7.0% moved the same wayICLR +15.5 · IQV +9.3 · MEDP +4.7 · INCY +0.2
+10.24%
15May 27, 2026
May 27, 2026Nothing in our recordNo CRL story, brief or results filing in our record that dayGroup +1.2% did not move with it
+1.2% did not move with itICLR +4.0 · IQV +2.2 · MEDP −0.3 · INCY +0.3
+4.95%
14May 15, 2026
May 15, 2026Before our storiesGroup −0.9% did not move with it
−0.9% did not move with itINCY −2.4 · MEDP −0.9 · IQV −0.9 · ICLR −0.6
−5.20%
13May 11, 2026
May 11, 2026Before our storiesGroup −2.2% did not move with it
−2.2% did not move with itICLR −4.4 · IQV −2.9 · INCY +1.8 · MEDP −1.6
−5.16%
12May 5, 2026
May 5, 2026Before our storiesGroup +5.8% moved the same way
+5.8% moved the same wayIQV +9.6 · ICLR +8.3 · MEDP +3.2 · INCY +0.3
+7.58%
11Apr 23, 2026
Apr 23, 2026Before our storiesGroup −8.1% moved the same way
−8.1% moved the same wayMEDP −22.6 · IQV −8.3 · ICLR −7.9 · INCY −1.3
−9.23%
10Mar 31, 2026
Mar 31, 2026Before our storiesGroup +4.3% moved the same way
+4.3% moved the same wayICLR +5.3 · MEDP +4.3 · INCY +4.2 · IQV +2.6
+8.00%
9Mar 12, 2026
Mar 12, 2026Before our storiesGroup −6.1% moved the same way
−6.1% moved the same wayICLR −7.5 · MEDP −7.1 · IQV −5.0 · INCY −2.8
−9.62%
8Mar 10, 2026
Mar 10, 2026Before our storiesGroup −2.8% moved the same way
−2.8% moved the same wayIQV −4.3 · ICLR −3.1 · MEDP −2.5 · INCY −1.1
−5.44%
7Feb 11, 2026
Feb 11, 2026Before our storiesGroup −3.9% did not move with it
−3.9% did not move with itICLR −7.9 · MEDP −5.0 · IQV −2.9 · INCY −1.2
−8.42%
6Feb 5, 2026
Feb 5, 2026Before our storiesGroup −7.1% moved the same way
−7.1% moved the same wayICLR −10.9 · IQV −10.7 · MEDP −3.6 · INCY +0.2
−8.89%
5Feb 3, 2026
Feb 3, 2026Before our storiesGroup −4.7% moved the same way
−4.7% moved the same wayIQV −11.9 · ICLR −6.0 · MEDP −3.3 · INCY −1.7
−5.54%
4Dec 3, 2025
Dec 3, 2025Before our storiesGroup +0.4% did not move with it
+0.4% did not move with itICLR +2.5 · MEDP −1.2 · IQV +0.7 · INCY +0.1
+5.67%
3Nov 5, 2025
Nov 5, 2025ResultsThe first close after a results filing (SEC 8-K, Item 2.02)Group +0.6% did not move with it
+0.6% did not move with itINCY +2.7 · MEDP +0.7 · ICLR +0.5 · IQV −0.4
−5.71%
2Oct 1, 2025
Oct 1, 2025Before our storiesGroup +6.5% moved the same way
+6.5% moved the same wayICLR +9.9 · IQV +7.3 · MEDP +5.8 · INCY +2.2
+8.96%
1Sep 30, 2025
Sep 30, 2025Before our storiesGroup +3.9% moved the same way
+3.9% moved the same wayICLR +7.1 · IQV +5.1 · MEDP +2.7 · INCY +1.1
+6.44%

A story on the same day is not a cause, and a group move is not proof either. Group: IQV, INCY, MEDP, ICLR, the largest companies in CRL’s SEC industry; “the same way” means the same direction and at least half as far. Prior-session closes only; not a call, not advice.

The numbers · FY2025, filed

SEC EDGAR

Market cap$14.0B

Revenue$4.0B−0.90%

Net income$-144.3M

EPS, diluted$-2.91−1555.00%

Operating margin0.6%

Return on equity-4.6%

Debt / equity0.51

All filed figures

Snapshot

SEC EDGAR · FY 2025-12-27

SectorHealthcare

Market Cap$14.0B

Enterprise Value$15.4B

Income$-144.3M

Sales$4.0B

Book/sh$66.40

Cash/sh$4.52

Dividend TTM—

Payout—

Employees—

IPO—

Quick Ratio1.02

Current Ratio1.29

Debt/Eq0.51

EPS (ttm)$-2.91

EPS this Y-1555.0%

EPS past 3/5Y—

Sales past 3/5Y0.3%

EPS Y/Y TTM-1555.0%

Sales Y/Y TTM-0.9%

Shs Outstand47.74M

ROA-2.0%

ROE-4.6%

ROIC0.8%

Gross Margin—

Oper. Margin0.6%

Profit Margin-3.6%

Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue by fiscal year

$3.5B

FY21

$4.0B

FY22

$4.1B

FY23

$4.0B

FY24

$4.0B

FY25

Operating leverage — margins

GrossOperatingNet

Financials, annual · income and cash flowSEC EDGAR · open ▸

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it

USD	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$3.5B	$4.0B	$4.1B	$4.0B	$4.0B
Gross Profit	—	—	—	—	—
Operating Income	$589.9M	$651.0M	$617.3M	$227.3M	$25.2M
Net Income	$391.0M	$486.2M	$474.6M	$22.2M	$-144.3M
Diluted EPS	$7.60	$9.48	$9.22	$0.20	$-2.91
Operating Cash Flow	$760.8M	$619.6M	$683.9M	$734.6M	$737.6M
Free Cash Flow	—	—	—	—	—

Same industry

In the screener →

IQV$44.5B INCY$25.1B MEDP$17.3B ICLR$13.2B ABSI$1.7B OABI$670M NRC$433M MXCT$121M

Build basket with CRL Screener

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.